ABOUND.70+ Trademark

Trademark Overview

On Friday, November 1, 2013, a trademark application was filed for ABOUND.70+ with the United States Patent and Trademark Office. The USPTO has given the ABOUND.70+ trademark a serial number of 86107655. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 10, 2021. This trademark is owned by Celgene Corporation. The ABOUND.70+ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others on the safety and effectiveness of drugs; conducting clinical trials for others on the safety and effectiveness of drugs for lung cancer; providing medical and scientific research information in the field of clinical trials
abound.70+

General Information

Serial Number86107655
Word MarkABOUND.70+
Filing DateFriday, November 1, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 10, 2021
Registration Number4682761
Registration DateTuesday, February 3, 2015
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 8, 2014

Trademark Statements

Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"70+"
Description of MarkThe mark consists of the wording "ABOUND.70+" in blue to the left of a blue triangle design.
Goods and ServicesConducting clinical trials for others on the safety and effectiveness of drugs; conducting clinical trials for others on the safety and effectiveness of drugs for lung cancer; providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 10, 2021
Primary Code042
First Use Anywhere DateThursday, May 1, 2014
First Use In Commerce DateThursday, May 1, 2014

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, September 10, 2021CANCELLED SEC. 8 (6-YR)
Monday, February 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 3, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, December 30, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 29, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 19, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 18, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 18, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 7, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 7, 2014NON-FINAL ACTION E-MAILED
Friday, November 7, 2014SU - NON-FINAL ACTION - WRITTEN
Tuesday, September 16, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 21, 2014USE AMENDMENT FILED
Tuesday, September 16, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 21, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, June 3, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 8, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 3, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 3, 2014ASSIGNED TO LIE
Monday, February 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 10, 2014EXAMINER'S AMENDMENT ENTERED
Monday, February 10, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 10, 2014EXAMINERS AMENDMENT E-MAILED
Monday, February 10, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, February 3, 2014ASSIGNED TO EXAMINER
Wednesday, November 13, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 5, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

abound trials clinical conducting drugs effectiveness safety others research information field